Program at a Glance
Day 1st, Thursday, October 19th

7:00

…On-demand streaming

Room 1Room 2

Room 3

Room 4

Sonic City Hall 1F
LARGE HALL

Sonic City Hall 2F
SMALL HALL

Sonic City Hall 4F
INTERNATIONALCONFERENCE ROOM

Sonic City Main Bldg 4F
OMIYA SONIC CIVIC HALL
401+402

Room 5

PosterExhibition
Session Room Break room

Sonic City Main Bldg. 4F Sonic City Main Bldg Sonic City Main Bldg
OMIYA SONIC CIVIC HALL B1F EXHIBITION
B1F EXHIBITION
HALL 2〜5
HALL 1
403+404

Program in English

8:00

9:00

10:00

9:00-9:45

9:00-9:40 Sponserd Educational Seminar

9:00-13:00

JSPE Council Meeting

Chair: Yuri Etani
Speaker: Jitsu Kato
Co-sponsored by Pﬁzer Japan Inc.

Poster Posting

10:00-10:30 Presidential Lecture
Pediatric Endocrinology as the basis of Healthy Life Course
Chair: Shin Amemiya
Speakers: Toru Kikuchi

9:55-10:00 Opening Remarks

10:40-11:55

10:40-11:55

10:40-11:55

Susumu Yokoya
Speakers: Ikuma Fujiwara
Shirou Matsumoto
Yoshiya Ito

Haruo Mizuno
Speakers: Ikuma Musha
Masanobu Kawai
Yukihiro Hasegawa

Chairs: Keiichi Ozono
Ikuko Takahashi
Speakers: Junko Ito
Yuji Oto
Takuo Kubota

The pain experience in childhood doesn't end at that time

10:00-18:20

Exhibition
10:40-11:55

Symposium 1
Symposium 2
Symposium 3
11:00 Preparation for great disaster Advance of growth hormone therapy Visionary management for life courseof pediatric endocrine disease 1
Chairs: Kimitoshi Nakamura
Chairs: Yuki Kawashima

Hands-on Seminar 1
Co-sponsored by
Medtronic Japan Co., Ltd.

12:00
12:10-13:00 Luncheon Educational Seminar 1 12:10-13:00 Luncheon Educational Seminar 2 12:10-13:00 Luncheon Educational Seminar 3 12:10-13:00 Luncheon Educational Seminar 4

Treatment and Management of Achondroplasia Tips for using rtCGM in patients Key points for assessing disease severity in patients with XLH Evaluation and treatment of zinc deﬁciency

13:00

Chair: Tomonobu Hasegawa
in pediatric endocrine practicewith childhood-onset diabetes Chair: Kenji Ihara
Speakers: Toshimi Michigami
Chair: Akira Ohtake
Speakers: Hiroko Kashiwagi
Chair: Tatsuhiko Urakami
Keita Okada
Speaker: Daisuke Sugawara
Atsushi Suzuki
Speaker: Tomoyuki Kawamura
Nobelpharma Co., Ltd./
Co-sponsored by BioMarin Pharmaceutical Japan K.K. Co-sponsored by Terumo Corporation Co-sponsored by Kyowa Kirin Co., Ltd Co-sponsored byMEDIPALHOLDINGS CORPORATION
13:00-17:20

13:10-14:25

Poster Display

Outstanding Abstruct
Session 1
14:00(SP1-1 〜 5)

Chairs: Kenji Ihara
Toshimi Michigami
14:25-15:40

15:00

Outstanding Abstruct
Session 2(SP2-1 〜 5)

Chairs: Kanshi Minamitani
Yukiyo Yamamoto
15:40-16:10

MoguMogu
Time

16:00
16:10-17:10

Oral Session 1
Pituitary and Growth 1(O1-1-1 〜 6)

Chairs: Tsuyoshi Isojima
Koji Muroya
17:00
17:20-18:20

Short Oral Session 1
Pituitary and Growth 3(SO1-1-1 〜 10)

18:00 Chairs: Michiko Okajima
Kenichi Miyako

16:10-17:10

Oral Session 2
Bone Metabolism 1(O1-2-1 〜 6)

16:10-17:10

16:10-17:10

Oral Session 3
Adrenal 1(O1-3-1 〜 6)

(O1-4-1 〜 6)

(O1-5-1 〜 6)

Chairs: Sachiko Kitanaka
Masanori Minagawa

Chairs: Tomohiro Ishii
Yasuhiro Naiki

Chairs: Kentaro Shiga
Junichi Suzuki

Chairs: Keiichi Hanaki
Mitsuhiko Hara

17:20-18:20

17:20-18:20

17:20-18:20

17:20-18:20

Short Oral Session 2
Bone Metabolism 3(SO1-2-1 〜 10)

Chairs: Yasuhisa Ohata
Hotaka Kamasaki

Short Oral Session 3
Adrenal and Thyroid(SO1-3-1 〜 10)

Chairs: Naoko Amano
Kei Takasawa

Short Oral Session 4
Diabetes and Hypoglycemia 4(SO1-4-1 〜 10)

Chairs: Yuki Abe
Hiroki Hirai

18:30-20:00

Evening Educational
Seminar
19:00 Updates in Diagnosis and Treatment ofPediatric Endocrine and Metabolic
Disorders - Living in an Era of Diversity -20:00

16:10-17:10

Oral Session 4
Oral Session 5
Diabetes and Hypoglycemia 1 Obesity, Underweight and Lipid 1

Chair: Reiko Horikawa
Speakers: Yasutaka Maeda
Tomohiro Ishii
Co-sponsored by Novo Nordisk Pharma Ltd.

Short Oral Session 5
CCS/Water and electrolyte
metabolism 2(SO1-5-1 〜 10)

Chairs: Akie Nakamura
Shizuyo Nagai

17:20-18:20

PosterSessionPoster Session 1
Pituitary and Growth 4(P1-1-1 ～ 8)
Chairs: Daisuke Ariyasu
Tomotaka Kono
Poster Session 2
Gonad and Puberty 4(P1-2-1 ～ 8)
Chairs: Yusuke Tanahashi
Michiyo Mizota
Poster Session 3
Diabetes and Hypoglycemia 6(P1-3-1 ～ 8)
Chairs: Junpei Hamada
Yuki Hosokawa
Poster Session 4
Diabetes and Hypoglycemia 7(P1-4-1 ～ 7)
Chairs: koji Kobayashi
Tomozumi Takatani
Poster Session 5
Obesity, Underweight and Lipid 4(P1-5-1 ～ 7)
Chairs: Junko Igaki
Yasuko Shoji
Poster Session 6
Thyroid 4(P1-6-1 ～ 7)
Chairs: Kiyomi Abe
Itsuro Kazukawa

🅔 =English Session― 79 ―

Program at a GlanceDay
Day2nd,2nd,Friday,
Friday,October
October20th
20th

8:00
8:00

…On-demand…On-demandstreaming
streaming

Room
Room11Room
Room22Room
Room33

Sonic
SonicCity
CityHallHall1F1F
LARGE
LARGEHALL
HALL

Sonic
SonicCity
CityHallHall2F2F
SMALL
SMALLHALL
HALL

Sonic
SonicCity
CityHallHall4F4F
INTERNATIONALINTERNATIONALCONFERENCECONFERENCEROOM
ROOM

Room
Room44

PosterPosterSessionSessionRoom
Room

Room
Room55

Sonic
SonicCity
CityMain
MainBldg
Bldg4F4F
Sonic
SonicCity
CityMain
MainBldg.
Bldg.4F4F
OMIYASONIC
SONICCIVIC
CIVICHALL
HALL
OMIYA
OMIYASONIC
SONICCIVIC
CIVICHALL
HALL OMIYA
403+404
403+404
401+402
401+402

Exhibition
Exhibition
Break
Breakroom
room

Sonic
SonicCity
CityMain
MainBldg
BldgB1FB1F Sonic
SonicCity
CityMain
MainBldg
BldgB1F
B1F
EXHIBITIONEXHIBITION
HALL
HALL2〜5
2〜5
EXHIBITIONEXHIBITIONHALL
HALL1 1

8:30-9:10
8:30-9:10
MorningMorningEducational
EducationalSeminar
Seminar

TRAJECTORY
TRAJECTORYto theto thefuture
futureof CAH
of CAHmanagement
management

Chair:
Chair:
Naoko
Naoko
Amano
Amano
Speaker:
Speaker:
KeiKeiTakasawa
Takasawa
Co-sponsoredCo-sponsored
byby
DENIS
DENIS
PharmaPharma
K.K.
K.K.

9:00
9:00
9:15-10:30
9:15-10:30

9:00-17:20
9:00-17:20

9:15-10:30
9:15-10:30

Symposium
Symposium4 4Practice
Practiceof ofpreconception
preconceptioncare
careforforchildhood-onset
childhood-onsetendocrine
endocrinediseases
diseases

9:15-10:15
9:15-10:15

Meet
MeetthetheExpert
Expert1 1
Diagnostic
Diagnosticapproach
approachtotocongenitalcongenital
malformation
malformationsyndromes
syndromes

Symposium
Symposium5 5
Let’s
Let’sstart
startmulticenter
multicenter
research
research

11:00
11:00Chair:
Chair:Reiko
ReikoHorikawa
Horikawa
Speaker:
Speaker:Hiroaki
HiroakiItoh
Itoh

Exhibition
Exhibition

Chair:Koji
Chair:KojiMuroya
MuroyaSpeaker:Kenji
Speaker:KenjiKurosawa
Kurosawa
Co-sponsoredCo-sponsored
by by
LSILSI
Medience
Medience
Corporation
Corporation

Chairs:Chairs:Kenji
KenjiIhara
Ihara
Chairs:Chairs:Kaori
KaoriFukawa
FukawaMie
MieMochizuki
Mochizuki
KanshiKanshiMinamitani
Minamitani
Speakers:
Speakers:Yukiyo
YukiyoYamamoto
Yamamoto
Speakers:
Speakers:
Naoko
Naoko
Arata
Arata
Maki
MakiKawasaki
Kawasaki
MasakoMasakoWaguri
Waguri
Chihaya
ChihayaImai
Imai
Kenichi
KenichiKashimada
Kashimada

10:00
10:00

10:40-11:15
10:40-11:15
Plenary
PlenaryLecture
Lecture1 1

PosterPosterDisplay
Display

9:00-18:20
9:00-18:20

10:40-11:40
10:40-11:40

Meet
MeetthetheExpert
Expert2 2
Geneti
Genetic testic testing forng forpedipedi
atricatrifami
c familial hyperchol
lial hyperchol
esterolesterolemieamia(FH)(FH)andandprimpriarymarydysldysl
ipidemiipidemia: practi
a: practi
cal cappl
al applicatiicoatinsons

History
Historyof ofnutritional
nutritionalguidance
guidanceforfor
pregnant
pregnantwomen
womenin inJapan
Japanandandlong-term
long-termprognosis
prognosisof ofthetheoﬀoﬀ
springspringChair:
Chair:Kazushige
KazushigeDobashi
DobashiSpeaker:
Speaker:Hayato
HayatoTada
Tada
Co-sponsoredCo-sponsoredbybyKUBIX
KUBIXInc.
Inc.

11:20-11:55
11:20-11:55
Plenary
PlenaryLecture
Lecture2 2

Diabetes
Diabetesmellitus
mellitusand
andpregnancy
pregnancy

Chair:
Chair:
Tomonobu
TomonobuHasegawa
Hasegawa
Speaker:
Speaker:
TakashiTakashiSugiyama
Sugiyama

12:00
12:00

12:05-12:55
12:05-12:55
12:05-12:55
12:05-12:55
12:05-12:55
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn5ar 512:05-12:55
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn6ar 612:05-12:55
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn7ar 712:05-12:55
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn8ar 8
TheThesigniﬁsigniﬁcance
cance
of earlyof early
diagnosis
diagnosisof HPPof HPP
learnilearni
ng throughng throughA new
A newtherapeuti
therapeutic optic oopti
n foron GH
for GH
deﬁcideﬁencyi
ciencyin chinldchirenldren
andandclinicclalinicalManagement
Managementof SGA
of SGA
shortshortstature
staturefromfromthethe
perspecti
perspecti
ve ve
ClinicalClinicalusefulness
usefulnessofof
the thepatient
patient
journey
journeyof Adultof Adult
HPP～Cl
HPP～Clinicalinicalchangeschangesof of guidgui
elindeselinfores thefor thediagnosi
diagnosis ands andtreatment
treatmentof GHof GH
deﬁcideﬁency
ciency2023.2023.
manifestations
overover
years
years
andandthe theinitiation
initiationof ERT～of ERT～of inofternati
internati
onalonalconsensus
consensusguidguielidnele ionne SGA
on SGA isCGM-Real-world
isCGM-Real-worldexperience
experience manifestations

Chair:
Chair:Jun
JunMoriMori
Chair:
Chair:
Keiichi
KeiichiOzono
Ozono
Chair:
Chair:
Kenichi
KenichiKashimadaKashimada
Chair:
Chair:Shigetaka
ShigetakaSugihara
Sugihara
Speakers:
Speakers:
Yasuhisa
Yasuhisa
Ohata
Ohata
Speaker:
Speaker:Sumito
SumitoDateki
DatekiSpeaker:
Speaker:
Yuya
Yuya
NakanoNakanoSpeaker:
Speaker:Tatsuhiko
TatsuhikoUrakami
UrakamiHiroaki
Hiroaki
MurataMurataCo-sponsored
byby
Novo
Novo
Nordisk
NordiskPharmaPharmaLtd.Ltd.
Co-sponsoredbyby
AlexionAlexionPharmaPharmaGKGKCo-sponsoredCo-sponsoredCo-sponsored
by by
JCRJCR
Pharmaceuticals
Pharmaceuticals
Co.,Co.,Ltd.Ltd.Co-sponsoredCo-sponsoredbyby
AbbottAbbottJapan
Japan
LLC
LLCCo-sponsored

13:00
13:00

13:05-14:15
13:05-14:15

14:00
14:00

AGM
AGMforforJSPE
JSPE
Award
AwardCeremony
Ceremony
JSPE
JSPEAwardAwardLecture
Lecture14:15-14:25
14:15-14:25

14:30-15:05
14:30-15:05

InvitedInvitedLecture
Lecture🅔🅔

VideoVideomessage
messageofofHanako
HanakoJimi,
Jimi,
a amembermemberofofthe
theHouse
HouseofofCouncilors
Councilors

The Theuse ofusetechnolof technol
ogy oforgyachi
for eachi
vingeviTinmgeTiinmRangee in Range
and and
TimeTiinmTie ginhtTirange
ght range

Chair:
Chair:Toru
ToruKikuchi
KikuchiSpeaker:Tadej
TadejBattelino
Battelino
15:00
15:00Speaker:

15:10-15:40
15:10-15:40
KSPE-JSPE
KSPE-JSPE
Plenary
Plenary
LectureLecture🅔🅔

MoleMolculaerculandar ClandinicClalinCharacteri
ical Characteri
sticssofticMonogeni
s of Monogeni
c Diacbetes
Diabetesin Koreanin KoreanChildChirenldrenChair:
Chair:Noriyuki
Noriyuki
Namba
Namba
Speaker:
Speaker:
Chong
Chong
Kun
Kun
Cheon
Cheon

15:40-16:10
15:40-16:10

MoguMogu
MoguMoguTime
Time

16:00
16:00
16:10-17:10
16:10-17:10

16:10-17:10
16:10-17:10

16:10-17:10
16:10-17:10

Oral
OralSession
Session6 6
Oral
OralSession
Session7 7
Diabetes
Diabetesand
andHypoglycemia
Hypoglycemia2 2Obesity,
Obesity,Underweight
Underweightand
andLipid
Lipid2 2(O2-6-1(O2-6-1〜〜6)6)(O2-7-1(O2-7-1〜〜6)6)

Chairs:Chairs:Tokuo
TokuoMukai
Mukai
Tohru
TohruYorifuji
Yorifuji

Chairs:Chairs:Rumi
RumiHachiya
HachiyaJun
JunMori
Mori

17:20-18:20
17:20-18:20

17:20-18:20
17:20-18:20

17:00
17:00

Oral
OralSession
Session8 8
Bone
BoneMetabolism
Metabolismand
andgenetic
geneticanalysis
analysis(O2-8-1(O2-8-1〜〜6)6)

Chairs:Chairs:Masayo
MasayoKagami
Kagami
SumitoSumitoDateki
Dateki
17:20-18:20
17:20-18:20

16:10-17:10
16:10-17:10

Oral
OralSession
Session9 9
Bone
BoneMetabolism
Metabolism2 2(O2-9-1(O2-9-1〜〜6)6)

16:10-17:10
16:10-17:10

Oral
OralSession
Session1010
Pituitary
PituitaryandandGrowth
Growth2 2(O2-10-1(O2-10-1〜〜
6)6)Chairs:Chairs:Takuo
TakuoKubota
Kubota
Kosei
KoseiHasegawa
Hasegawa

Chairs:Chairs:Yoshiya
YoshiyaItoIto
Shun
ShunSoneda
Soneda17:20-18:20
17:20-18:20

17:20-18:20
17:20-18:20

17:20-18:20
17:20-18:20

Short
ShortOral
OralSession
Session6 6 Short
ShortOral
OralSession
Session7 7 Short
ShortOral
OralSession
Session8 8 Short
ShortOral
OralSession
Session9 9 Short
ShortOral
OralSession
Session1010
PosterPosterSession
SessionDiabetes
Diabetesand
andHypoglycemia
Hypoglycemia5 5Obesity,
Obesity,Underweight
Underweightand
andLipid
Lipid3 3
ThyroidThyroid3 3
Gonad
Gonadand
andPuberty
Puberty3 3
Diabetes
DiabetesandandThyroid
Thyroid(SO2-6-1(SO2-6-1
〜〜
10)
10)

(SO2-7-1(SO2-7-1〜〜
9)9)(SO2-8-1(SO2-8-1
〜〜
10)
10)

Shigeru
ShigeruSuzuki
Suzuki

Chairs:Chairs:Go
GoIchikawa
Ichikawa
Kouji
KoujiTakemoto
Takemoto

Chairs:Chairs:Masatsune
MasatsuneItoh
Itoh
IchiroIchiroMiyata
Miyata18:00
18:00Chairs:
Chairs:KazuhikoKazuhikoJinno
Jinno(SO2-9-1(SO2-9-1
〜〜
10)
10)

Chairs:Chairs:Takashi
TakashiHamajima
Hamajima
YasukoYasukoFujisawa
Fujisawa

18:45-21:00
18:45-21:00

19:00
19:00

BanquetBanquet
PLACE
PLACEHOTEL
HOTEL
OMIYA
OMIYA

20:00
20:00

21:00
21:00

― 80 ―(SO2-10-1(SO2-10-1
〜〜
10)
10)

Chairs:Chairs:Tomoyuki
TomoyukiHotsubo
HotsuboKatsuyuki
KatsuyukiMatsui
Matsui

PosterPosterSession
Session7 7
Pituitary
PituitaryandandGrowth
Growth5 5～～7)7)(P2-7-1(P2-7-1
Chairs:Chairs:Naoaki
NaoakiHori
Hori
Yasunori
YasunoriWada
Wada
PosterPosterSession
Session8 8
AdrenalAdrenal2 2～～8)8)(P2-8-1(P2-8-1
Chairs:Chairs:Tomoyo
TomoyoItonaga
Itonaga
Kayo
KayoOzaki
Ozaki
PosterPosterSession
Session9 9
Gonad
Gonadand
andOthers
Others～～7)7)(P2-9-1(P2-9-1
Chairs:Chairs:Masako
MasakoIzawa
Izawa
Hisafumi
HisafumiMatsuoka
Matsuoka
PosterPosterSession
Session1010
Diabetes
DiabetesandandHypoglycemia
Hypoglycemia8 8(P2-10-1(P2-10-1～～
6)6)Chairs:Chairs:Tadayuki
Tadayuki
Ayabe
Ayabe
Kaori
KaoriFukawa
FukawaPosterPosterSession
Session1111
ThyroidThyroid5 5～～7)7)(P2-11-1(P2-11-1
Chairs:Chairs:Rie
RieMatsushita
Matsushita
Yuichi
YuichiMushimoto
Mushimoto
PosterPosterSession
Session1212
Bone
BoneMetabolism
Metabolism4 4～～8)8)(P2-12-1(P2-12-1
Chairs:Chairs:Taichi
TaichiKitaoka
Kitaoka
Masaki
MasakiTakagi
Takagi
PosterPosterSession
Session1313
CCS/Water
CCS/Waterand
andelectrolyte
electrolyte
metabolism
metabolism3 3～～8)8)(P2-13-1(P2-13-1
Chairs:Chairs:Junko
JunkoItoIto
Tomohiro
TomohiroHori
Hori

Session
🅔🅔=English=EnglishSession

Program at a GlanceDay
Day3rd,3rd,Saturday,
Saturday,October
October21st
21st

8:00
8:00

Room
Room11Room
Room22

Sonic
SonicCity
CityHallHall1F1F
LARGE
LARGEHALL
HALL

Sonic
SonicCity
CityHallHall2F2F
SMALL
SMALLHALL
HALL

9:00-10:15
9:00-10:15

9:00-10:15
9:00-10:15

Room
Room33Room
Room44

PosterPosterSessionSessionRoom
Room

Room
Room55

Exhibition
Exhibition
Break
Breakroom
room

Sonic
SonicCity
CityMain
MainBldg
Bldg4F4F Sonic
SonicCity
CityMain
MainBldg.
Bldg.4F4F
Sonic
SonicCity
CityHallHall4F4F
SonicCity
CityMain
MainBldg
BldgB1FB1F Sonic
SonicCity
CityMain
MainBldg
BldgB1F
B1F
OMIYASONIC
SONICCIVIC
CIVICHALL
HALLSonic
INTERNATIONALINTERNATIONALOMIYAOMIYASONIC
SONICCIVIC
CIVICHALL
HALLOMIYAEXHIBITIONEXHIBITIONHALL
HALL2〜52〜5 EXHIBITIONEXHIBITIONHALL
HALL1 1
CONFERENCECONFERENCEROOM
ROOM
403+404
403+404
401+402
401+402

9:00-10:15
9:00-10:15

9:00-10:30
9:00-10:30

Symposium
Symposium6 6
Symposium
Symposium7 7
Committee
CommitteeononGEGEandandWLBWLBJoint
JointSymposium
Symposium
Approach
Approachforforchildhood,childhood,adolescentsadolescents Symposi
Symposiumum7, Visi
7, Visionary
onarymanagement
managementforfor Progress
Progressof pediof pediatriactriendocric endocri
nolongy
ologythroughthroughandandyoung
youngadulthood
adulthoodsever
severobesity
obesity lifelifecourse
courseof ofpedipedi
atriactriendocric endocri
nendiseasee disease2 2 diversi
diversity, tthiy,nthikingkinabout
g aboutdiverse
diverseacademi
academic careersc careers

9:00-15:20
9:00-15:20

Meet
MeetthetheExpert3
Expert3

PosterPosterDisplay
Display

Recommendations
Recommendationsforfor“Motivational“MotivationalInterviewing”
Interviewing”

Chairs:Chairs:Mikako
MikakoInokuchi
InokuchiChairs:Chairs:Satoshi
SatoshiOkada
Okada
Chairs:Chairs:Hideaki
HideakiYagasaki
YagasakiSatomi
SatomiKoyama
KoyamaYoshihiro
YoshihiroMaruo
Maruo
Akari
AkariUtsunomiya
Utsunomiya
Speakers:
Speakers:MitsuhikoMitsuhikoHara
Hara
Speakers:
Speakers:Masahiko
MasahikoKawai
Kawai Speakers:
Speakers:Eiichiro
EiichiroSatake
SatakeMotoyoshi
MotoyoshiTsujino
TsujinoKeisuke
KeisukeNagasaki
Nagasaki
Mari
MariMurashita
Murashita
10:00
10:00
Keigo
KeigoYada
Yada
Yoko
YokoMiyoshi
Miyoshi
Miyuki
MiyukiKatai
Katai

Chair:
Chair:Masakazu
MasakazuHirose
HiroseSpeaker:
Speaker:Tomoyuki
TomoyukiKawamura
Kawamura

9:00-14:30
9:00-14:30

Exhibition
Exhibition

10:15-10:45
10:15-10:45

MoguMogu
MoguMoguTimeTime
10:45-11:25
10:45-11:25

11:00
11:00

Oral
OralSession
Session1111
Gonad
Gonadand
andPuberty
Puberty1 1(O3-11-1(O3-11-1〜〜4)4)Chairs:Chairs:Masanobu
MasanobuKawai
Kawai
Maki
MakiFukami
Fukami
11:25-12:05
11:25-12:05

Oral
OralSession
Session1212
Gonad
Gonadand
andPuberty
Puberty2 2(O3-12-1〜(O3-12-1〜
4)4)Chairs:Chairs:Yoshiaki
YoshiakiOhtsu
Ohtsu
Shinichiro
ShinichiroSano
Sano

12:00
12:00

10:45-11:25
10:45-11:25

Oral
OralSession
Session1313
ThyroidThyroid1 1(O3-13-1(O3-13-1〜〜4)4)

10:45-11:25
🅔🅔10:45-11:25

10:45-11:25
10:45-11:25

OralSession
Session1515
EnglishEnglishOral
OralSession
Session1 1 OralCCS/
CCS/Water
Waterandandelectrolyte
electrolytemetabol
metabol
ismism1 1(EO1-1(EO1-1〜〜4)4)

Chairs:Chairs:Asako
AsakoTajima
TajimaChairs:Chairs:Satoshi
SatoshiNarumi
Narumi
Yukihiro
YukihiroHasegawa
Hasegawa
Chikahiko
ChikahikoNumakura
Numakura
11:25-12:05
11:25-12:05

Oral
OralSession
Session1414
ThyroidThyroid2 2(O3-14-1(O3-14-1〜〜
4)4)Chairs:Chairs:Kazumichi
KazumichiOnigata
Onigata
Keisuke
KeisukeNagasaki
Nagasaki

11:25-11:55
11:25-11:55(O3-15-1(O3-15-1〜〜4)4)Chairs:Chairs:Masanori
Masanori
AdachiAdachi
Junko
JunkoKanno
Kanno

11:25-12:05
🅔🅔11:25-12:05

OralSession
Session1616
EnglishEnglishOral
OralSession
Session2 2 Oral
Diabetes
Diabetesand
andHypoglycemia
Hypoglycemia3 3(EO2-1(EO2-1〜〜3)3)

Chairs:Chairs:Kenichi
KenichiKashimada
Kashimada
Eiichiro
EiichiroSatake
Satake(O3-16-1(O3-16-1〜〜
4)4)Chairs:Chairs:katsuya
katsuya
Aizu
Aizu
Katsuyuki
KatsuyukiMatsui
Matsui12:15-13:05
12:15-13:05
12:15-13:05
12:15-13:05
12:15-13:05
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn9ar 912:15-13:05
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn10ar 10 12:15-13:05
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn11ar 11 12:15-13:05
Luncheon
Luncheon
Educati
Educationalonal
SemiSemi
narn12ar 12

Treatment
Treatmentand
andManagement
Managementofof Innovative
SHOX
SHOXabnormal
abnormalities:
ities:from
fromitsitsdiscovery
discovery
A Arisingrisingstar
starininGHD
GHD
InnovativeApproaches
Approachesto Control
to Control
lingling
Complicationsin in
Achondroplasia
AchondroplasiaGlycemi
to todiagnostic
diagnosticandandtherapeutic
therapeuticprogress
progress treatment–SOMATROGON
treatment–SOMATROGON Complications
Glycemic FlcuFlctuati
uctuationsonsin DiinaDibetes
abetesTreatment
Treatment

Chair:
Chair:Ikuma
IkumaFujiwara
Fujiwara
Chair:
Chair:Maki
MakiFukami
Fukami
Chair:
Chair:Tomohiro
TomohiroIshii
Ishii
Chair:
Chair:Noriyuki
Noriyuki
TakuboTakuboSpeakers:
Speakers:Naoki
NaokiKagawa
KagawaSpeaker:
Speaker:Tsutomu
TsutomuOgata
Ogata
Speaker:
Speaker:Masanori
Masanori
AdachiAdachiSpeakers:Rimei
RimeiNishimura
Nishimura
Sota
SotaYamaguchi
Yamaguchi Speakers:
Co-sponsored
byby
PﬁPﬁ
zerzerJapan
Japan
Inc.
Inc.Co-sponsoredCo-sponsoredbyby
EliEli
Lilly
LillyJapan
Japan
K.K.
K.K.
Co-sponsored
by by
JCRJCR
Pharmaceuticals
Pharmaceuticals
Co.,Co.,Ltd.Ltd.Co-sponsoredCo-sponsored
by BibyoBiMarioMarin Pharmaceutin Pharmaceuti
cal cJapanal Japan
K.K.K.K.Co-sponsored
13:00
13:00Co-sponsored
13:15-14:30
13:15-14:30

13:15-14:30
13:15-14:30

13:15-14:15
13:15-14:15

Symposium
Symposium8 8
Symposium
Symposium9 9
AchiAchievement
evementfor forthetheDisDicovery
scoveryof IofnsulInisul
n, celin, ecelbrati
ebrating ngLet’s
Let’smakemakefullfulluse
useofofclinicalclinicalthethe100th
100thannianni
versary
versaryof theof theNobel
NobelPrizPrie ze
genetic
genetictesting
testing

Meet
MeetthetheExpert
Expert4 4
Revisiting
RevisitingTriiodothyronine
Triiodothyronine
andandThyroxine
Thyroxine

Chairs:Chairs:Nobuyuki
NobuyukiKikuchi
Kikuchi
Chairs:Chairs:Toshimi
ToshimiMichigami
Michigami
Noriyuki
NoriyukiTakubo
TakuboTakeshiTakeshiUsui
Usui
Speakers:
Speakers:Masakazu
MasakazuHirose
Hirose Speakers:
Speakers:
Akie
AkieNakamura
Nakamura
Yohei
YoheiOgawa
Ogawa
Junichi
JunichiHosokawa
Hosokawa
Masae
MasaeMinami
Minami
Keiko
KeikoMatsubara
Matsubara

14:00
14:00

14:40-15:10
14:40-15:10

Plenary
PlenaryLecture
Lecture3 3
CommitteeononGE
GEand
and
15:00
15:00 Committee
WLB
WLBJoint
JointSession
Session

Chair:
Chair:Yasuhisa
YasuhisaOhata
Ohata
Speaker:
Speaker:Satoshi
SatoshiNarumi
NarumiA rareA rareendocrine
endocrinediseasediseasehighlights
highlights
newneweraeraof ofGPCR
GPCRregulation
regulation

Chair:
Chair:Toshihiro
ToshihiroTajima
TajimaSpeaker:
Speaker:Noriko
NorikoMakita
Makita15:20-16:00
15:20-16:00

15:10-15:20
15:10-15:20

PosterPosterRemoval
RemovalGreetings
Greetingsofofthe
thenext
nextmeeting
meetingchair
chairparson
parsonandandClosing
ClosingRemarks
Remarks

16:00
16:00

17:00
17:00

18:00
18:00

19:00
19:00

20:00
20:00

Session
🅔🅔=English=EnglishSession― 81 ―

Program in English

9:00
9:00

…On-demand…On-demandstreaming
streaming

Invited Lecture
October, 20（Fri.）14:30 ～ 15:05
Chair		

Room 1（Sonic City Hall 1F LARGE HALL）

Toru Kikuchi（Department of Pediatrics,Saitama Medical University）

The use of technology for achieving Time in Range and Time in Tight range
Tadej Battelino
University Medical Center Ljubljana, Faculty of Medicine, University of Ljubljana, Slovenia
KSPE-JSPE Plenary Lecture
October, 20（Fri.）15:10 ～ 15:40
Chair		

Room 1（Sonic City Hall 1F LARGE HALL）

Noriyuki Namba（Division of Pediatrics and Perinatology, Tottori University Faculty of
Medicine）

	Molecular and Clinical Characteristics of Monogenic Diabetes in KoreanChildrenChong Kun Cheon
Pusan National University School of Medicine, Yangsan, Korea / Pusan National University
Children’s Hospital, Yangsan, Korea
English Oral Session 1
October 21（Sat.）10:45 ～ 11:25 Room 3（Sonic City Hall 4F INTER NATIONAL CONFERENCE ROOM）
Chairs				

Asako Tajima（Division of Endocrinology and Metabolism, Saitama Children’s Medical Center）
Yukihiro Hasegawa（Division of Endocrinology and Metabolism, Tokyo Metropolitan
Children’s Medical Center）

EO1-1	Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year
Results from REAL4
Yasuko Fujisawa1, Yasuko Fujisawa1, Jun Mori2, Yasuhisa Ohata3, Yukihito Sato4,
Sebastian Rohrich5, Michael Hojby Rasmussen6, Rikke Beck Bang7, Reiko Horikawa8
1
Dept. of Pediatr., Hamamatsu Univ. Sch. of Med.,
2
Div. of Pediatr. Endo. and Metabolism, Children’s Medical Center, Osaka City General
Hosp.,
3
Dept. of Pediatr., Osaka Univ. Grad. School of Med.,
4
Novo Nordisk Pharma Ltd., Tokyo, Japan,
5
Global Medical Affairs, Rare Endo. Disorders, Novo Nordisk Health Care AG, Zurich,
Switzerland,
6
Clinical Drug Development, Novo Nordisk A/S, Søborg, Denmark,7
Novo Nordisk A/S, Aalborg, Denmark,8
Div. of Endo. and Metabolism, Nat. Center for Child Health and Dev.
EO1-2	Model-based analysis of IGF-I response, dosing, and monitoring for onceweekly somapacitan in children with GH deficiency
Jun Mori1, Rasmus Juul Kildemoes2, Yassine Kamal Lyauk2, Joanne C. Blair3, Bradley S. Miller4,
Michael Højby Rasmussen2, Philippe F. Backeljauw5
1
Division of Pediatric Endocrinology and Metabolism, Children’s Medical Center, Osaka City
General Hospital, Osaka, Japan,
2
Novo Nordisk A/S, Søborg, Denmark,3
Department of Endocrinology, Alder Hey Children’s NHS Foundation Trust, Liverpool,
United Kingdom,
4
Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth
Fairview Masonic Children’s Hospital, Minneapolis, Minnesota, USA,
5
Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine,
Cincinnati, Ohio, USA― 82 ―

English Oral Session 2
October 21（Sat.）11:25 ～ 11:55 Room 3（Sonic City Hall 4F INTER NATIONAL CONFERENCE ROOM）
Chairs				Kenichi Kashimada（Department of Pediatrics and Developmental Biology, Tokyo Medical and
Dental University（TMDU））
Eiichiro Satake（Genetics and Epidemiology, Joslin Diabetes Center）

EO2-1	Persistence to growth hormone treatment and clinical characteristics of
paediatric patients with growth hormone deficiency: A retrospective
database study
Sumito Dateki1, Yukihito Sato2, Jun Mori3
1
Dept. of Pediat., Nagasaki Univ. Graduate School of Biomedical Sciences, Nagasaki, Japan,
2
Novo Nordisk Pharma Ltd., Tokyo, Japan,
3
Division of Pediatric Endocrinology and Metabolism, Children’s Medical Center, Osaka City
General Hospital, Osaka, Japan― 83 ―

Program in English

EO1-3	Patient preference questionnaire response after switching to somapacitan
after taking daily growth hormone: 2-year results from REAL 4
Jun Mori1, Joanne C. Blair2, Bradley S. Miller3, Michael Hojby Rasmussen4, Aristides Maniatis5,
Volker Böttcher6, Ho-Seong Kim7, Rikke Beck Bang8, Lasse De Fries Jensen3, Michel Polak9,
Reiko Horikawa10
1
Division of Pediatric Endocrinology and Metabolism, Children’s Medical Center, Osaka City
General Hospital, Osaka, Japan,
2
Department of Endocrinology, Alder Hey Children’s NHS Foundation Trust, Liverpool,
United Kingdom,
3
Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth
Fairview Masonic Children’s Hospital, Minneapolis, Minnesota, USA,
4
Novo Nordisk A/S, Søborg, Denmark,5
Rocky Mountain Pediatric Endocrinology, Centennial, CO, USA,
6
Division of Pediatric Endocrinology and Metabolism, MVZ Endokrinologikum Frankfurt
am Main, Frankfurt, Germany,
7
Department of Pediatrics, Severance Children’s Hospital, Institute of Endocrinology, Yonsei
University College of Medicine, Seoul, Republic of Korea,
8
Novo Nordisk A/S, Aalborg, Denmark,9Service d’Endocrinologie, Gynécologie et Diabétologie Pédiatriques, Hôpital Universitaire
Necker Enfants Malades Paris, Assistance Publique-Hôpitaux de Paris, Paris, France,
10
Division of Endocrinology and Metabolism, National Center for Child Health andDevelopment, Tokyo, Japan
EO1-4	Effect of Once-Weekly Somatrogon and Once-Daily Somatropin on Body
Mass Index and Metabolic Parameters: Post Hoc Analysis of the Pivotal
Phase 3 Trial
Mohamad Maghnie1, Aristides Maniatis2, Cheri Deal3, Lawrence Silverman4, Monica Nijher5,Michael Wajnrajch6,7, Marc Thomas5, Jose Cara6
1
Clinica Pediatrica, IRCCS Istituto Giannina Gaslini, and DINOGMI, University of Genova,
2
Rocky Mountain Pediatric Endocrinology, Centennial, CO, USA,
3
Centre de recherche CHU Ste-Justine, Université de Montréal, Montréal, Canada,
4
Goryeb Children’s Hospital, Morristown, NJ, USA,
5
Pfizer Ltd, Tadworth,  UK, 6Pfizer Inc, New York, NY, USA,
7
New York University, Grossman School of Medicine, New York, NY, USAEO2-2	A case of Graves’ disease diagnosed after treatment of idiopathic nephrotic
syndrome in childhood
Chisato Narita1, Naoto Nishizaki2, Noriyuki Takubo3, Naoto Shimura1, Toshiaki Shimizu4
1
Dept. of Pediatr. / Tokyo Rinkai Hosp. ,2
Dept. of Pediatr., Juntendo Univ. Sch. of Med. / Urayasu Hosp. ,3
Dept. of Pediatr., Juntendo Univ. Sch. of Med. / Juntendo Hosp.,
4
Dept. of Pediatr., Juntendo Univ. Grad. Sch. of Med.
EO2-3	Long-term effectiveness and safety of growth hormone therapy in Japanesechildren with short stature due to Noonan syndrome: real-world data.
Koji Muroya1, Masanobu Kawai2, Hiroyuki Yamagishi3, Takaaki Endo4, Alberto Pietropoli5,
Reiko Horikawa6
1
Department of Endocrinology and Metabolism, Kanagawa Children’s Medical Center,2
Department of Gastroenterology, Nutrition and Endocrinology, Research Institute, Osaka
Women’s and Children’s Hospital,
3
Division of Pediatric Cardiology, Department of Pediatrics, Keio University School of
Medicine,
4
Novo Nordisk Pharma Ltd., Medical affairs department,
5
Novo Nordisk Health Care AG,
6
Division of Endocrinology and Metabolism, National Center for Child Health andDevelopment― 84 ―